Futura Pens Deal With Cooper To Launch Erectile Dysfunction Gel In Europe

Futura Medical's novel OTC topical erectile dysfunction treatment MED3000 will be launched across numerous European markets by France's Cooper Consumer Health.

Europe signpost (Jason Winter/Shutterstock.com)
• Source: Shutterstock

UK-based Futura Medical plc has struck a deal with Cooper Consumer Health for the launch of its topical, gel-based erectile dysfunction (ED) treatment MED3000 across Europe.

More from Europe

More from Geography